Insider Transactions in Q4 2024 at Avidity Biosciences, Inc. (RNA)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 18
2024
|
Teresa Mc Carthy Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
11,151
-11.86%
|
$356,832
$32.66 P/Share
|
|
Dec 18
2024
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
31,855
-10.72%
|
$1,019,360
$32.66 P/Share
|
|
Dec 18
2024
|
Michael F Mac Lean Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,151
-11.85%
|
$356,832
$32.66 P/Share
|
|
Dec 18
2024
|
W. Michael Flanagan CSTO |
SELL
Open market or private sale
|
Direct |
12,742
-14.92%
|
$407,744
$32.66 P/Share
|
|
Dec 16
2024
|
Teresa Mc Carthy Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
25,000
-21.01%
|
$825,000
$33.26 P/Share
|
|
Dec 16
2024
|
Teresa Mc Carthy Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+17.36%
|
$350,000
$14.22 P/Share
|
|
Dec 11
2024
|
W. Michael Flanagan CSTO |
SELL
Open market or private sale
|
Direct |
24,000
-21.94%
|
$840,000
$35.77 P/Share
|
|
Dec 11
2024
|
W. Michael Flanagan CSTO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+17.99%
|
$528,000
$22.47 P/Share
|
|
Nov 19
2024
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
3,323
-18.31%
|
$139,566
$42.12 P/Share
|
|
Nov 19
2024
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,323
+15.47%
|
$3,323
$1.24 P/Share
|
|
Nov 18
2024
|
Teresa Mc Carthy Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
25,000
-21.01%
|
$1,025,000
$41.14 P/Share
|
|
Nov 18
2024
|
Teresa Mc Carthy Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+17.36%
|
$350,000
$14.22 P/Share
|
|
Nov 06
2024
|
Michael F Mac Lean Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
106,319
-25.41%
|
$4,784,355
$45.63 P/Share
|
|
Nov 06
2024
|
Michael F Mac Lean Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
79,057
+20.21%
|
$553,399
$7.7 P/Share
|
|
Oct 21
2024
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
5,000
-25.21%
|
$230,000
$46.63 P/Share
|
|
Oct 21
2024
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.14%
|
$5,000
$1.24 P/Share
|
|
Oct 16
2024
|
Teresa Mc Carthy Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
25,000
-21.01%
|
$1,200,000
$48.52 P/Share
|
|
Oct 16
2024
|
Teresa Mc Carthy Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+17.36%
|
$350,000
$14.22 P/Share
|
|
Oct 07
2024
|
Tamar Thompson Director |
SELL
Open market or private sale
|
Direct |
30,000
-100.0%
|
$1,320,000
$44.98 P/Share
|
|
Oct 07
2024
|
Tamar Thompson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
$810,000
$27.63 P/Share
|
|
Oct 01
2024
|
W. Michael Flanagan CSTO |
SELL
Open market or private sale
|
Direct |
62,500
-42.26%
|
$2,937,500
$47.62 P/Share
|
|
Oct 01
2024
|
W. Michael Flanagan CSTO |
BUY
Exercise of conversion of derivative security
|
Direct |
62,500
+29.71%
|
$1,625,000
$26.75 P/Share
|